1. Home
  2. FSM vs TVTX Comparison

FSM vs TVTX Comparison

Compare FSM & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSM
  • TVTX
  • Stock Information
  • Founded
  • FSM 1990
  • TVTX 2008
  • Country
  • FSM Canada
  • TVTX United States
  • Employees
  • FSM N/A
  • TVTX N/A
  • Industry
  • FSM Precious Metals
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSM Basic Materials
  • TVTX Health Care
  • Exchange
  • FSM Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • FSM 2.3B
  • TVTX 1.4B
  • IPO Year
  • FSM N/A
  • TVTX N/A
  • Fundamental
  • Price
  • FSM $6.60
  • TVTX $16.91
  • Analyst Decision
  • FSM Hold
  • TVTX Strong Buy
  • Analyst Count
  • FSM 1
  • TVTX 16
  • Target Price
  • FSM $7.00
  • TVTX $33.33
  • AVG Volume (30 Days)
  • FSM 13.3M
  • TVTX 1.4M
  • Earning Date
  • FSM 08-06-2025
  • TVTX 07-31-2025
  • Dividend Yield
  • FSM N/A
  • TVTX N/A
  • EPS Growth
  • FSM N/A
  • TVTX N/A
  • EPS
  • FSM 0.51
  • TVTX N/A
  • Revenue
  • FSM $1,151,277,000.00
  • TVTX $273,533,000.00
  • Revenue This Year
  • FSM N/A
  • TVTX $73.84
  • Revenue Next Year
  • FSM N/A
  • TVTX $46.72
  • P/E Ratio
  • FSM $12.92
  • TVTX N/A
  • Revenue Growth
  • FSM 32.69
  • TVTX 75.65
  • 52 Week Low
  • FSM $3.86
  • TVTX $7.93
  • 52 Week High
  • FSM $7.55
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • FSM 50.81
  • TVTX 62.88
  • Support Level
  • FSM $6.23
  • TVTX $14.44
  • Resistance Level
  • FSM $6.83
  • TVTX $16.64
  • Average True Range (ATR)
  • FSM 0.28
  • TVTX 0.63
  • MACD
  • FSM -0.01
  • TVTX 0.34
  • Stochastic Oscillator
  • FSM 50.00
  • TVTX 86.15

About FSM Fortuna Silver Mines Inc (Canada)

Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: